HW&C
HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
|
AARD
301
Aardvark Therapeutics, Inc. Common Stock
AARD
$178M
|
RS
Raghuram Selvaraju
| $8.20 | $40 |
388%
upside
| Buy |
30 Jun ‘25
2 months ago |
|
302
Inuvo
INUV
$51.4M
|
SB
Scott Buck
| $3.52 | $15 |
326%
upside
| Buy |
30 Jun ‘25
2 months ago |
|
|
LGO
303
Largo
LGO
$95.6M
|
HI
Heiko Ihle
| $1.49 | $3.70 |
148%
upside
| Buy |
30 Jun ‘25
2 months ago |
|
304
Edesa Biotech
EDSA
$17M
|
YC
Yi Chen
| $2.42 | $5 |
107%
upside
| Buy |
27 Jun ‘25
2 months ago |
|
305
Plus Therapeutics
PSTV
$47.4M
|
SL
Sean Lee
| $0.4778 | $3 |
528%
upside
| Buy |
27 Jun ‘25
2 months ago |
|
306
Crinetics Pharmaceuticals
CRNX
$3.31B
|
DT
Douglas Tsao
| $35.14 | $81 |
131%
upside
| Buy |
27 Jun ‘25
2 months ago |
|
307
Orion Energy Systems
OESX
$26M
|
AD
Amit Dayal
| $7.38 | $20 |
171%
upside
| Buy |
27 Jun ‘25
2 months ago |
|
|
IRD
308
Opus Genetics, Inc. Common Stock
IRD
$83.9M
|
MC
Matthew Caufield
| $1.40 | $8 |
471%
upside
| Buy |
27 Jun ‘25
2 months ago |
|
|
HIVE
309
HIVE Digital Technologies
HIVE
$597M
|
MC
Mike Colonnese
| $2.60 | $6 |
131%
upside
| Buy |
27 Jun ‘25
2 months ago |
|
310
Alto Neuroscience
ANRO
$105M
|
PT
Patrick Trucchio
| $3.89 | $10 |
157%
upside
| Buy |
26 Jun ‘25
2 months ago |
|
311
Invivyd
IVVD
$243M
|
PT
Patrick Trucchio
| $1.16 | $5 |
331%
upside
| Buy |
26 Jun ‘25
2 months ago |
|
312
Kymera Therapeutics
KYMR
$3.09B
|
AF
Andrew Fein
| $43.26 | $60 |
39%
upside
| Buy |
26 Jun ‘25
2 months ago |
|
313
Acadia Pharmaceuticals
ACAD
$4.28B
|
AF
Andrew Fein
| $25.39 | $32 |
26%
upside
| Buy |
26 Jun ‘25
2 months ago |
|
314
Cognition Therapeutics
CGTX
$212M
|
RS
Raghuram Selvaraju
| $2.40 | $3 |
25%
upside
| Buy |
26 Jun ‘25
2 months ago |
|
315
Phio Pharmaceuticals
PHIO
$12.1M
|
JP
Joseph Pantginis
| $2.12 | $14 |
560%
upside
| Buy |
25 Jun ‘25
2 months ago |
|
316
Aclaris Therapeutics
ACRS
$225M
|
RS
Raghuram Selvaraju
| $2.08 | $16 |
669%
upside
| Buy |
25 Jun ‘25
2 months ago |
|
317
Sarepta Therapeutics
SRPT
$1.84B
|
MK
Mitchell Kapoor
| $17.60 | $10 |
43%
downside
| Sell |
25 Jun ‘25
2 months ago |
|
318
US Gold Corp
USAU
$179M
|
HI
Heiko Ihle
| $12.78 | $15 |
17%
upside
| Buy |
25 Jun ‘25
2 months ago |
|
319
Sangamo Therapeutics
SGMO
$158M
|
PT
Patrick Trucchio
| $0.5250 | $10 |
1,805%
upside
| Buy |
24 Jun ‘25
2 months ago |
|
320
Nektar Therapeutics
NKTR
$843M
|
AH
Arthur He
| $44.33 | $120 |
171%
upside
| Buy |
24 Jun ‘25
2 months ago |
|
321
Nuvalent
NUVL
$5.76B
|
SR
Swayampakula Ramakanth
| $79.83 | $130 |
63%
upside
| Buy |
24 Jun ‘25
2 months ago |
|
322
Cidara Therapeutics
CDTX
$1.58B
|
JP
Joseph Pantginis
| $62.15 | $53 |
15%
downside
| Buy |
24 Jun ‘25
2 months ago |
|
323
Lyell Immunopharma
LYEL
$250M
|
MK
Mitchell Kapoor
| $13.03 | $10 |
23%
downside
| Neutral |
24 Jun ‘25
2 months ago |
|
324
Actinium Pharmaceuticals
ATNM
$49.9M
|
JP
Joseph Pantginis
| $1.60 | $4 |
150%
upside
| Buy |
24 Jun ‘25
2 months ago |
|
325
Ocugen
OCGN
$322M
|
SR
Swayampakula Ramakanth
| $1.03 | $7 |
580%
upside
| Buy |
24 Jun ‘25
2 months ago |
|